Senators Grassley and Cantwell Continue Efforts to Ensure Patients, Employers and Unions
No Longer Overpay for Prescriptions
Feb. 13, 2025 – Senators Charles Grassley (R-IA) and Maria Cantwell (D-WA) re-introduced bipartisan legislation, the Prescription Pricing for the People Act (S.527) and Pharmacy Benefit Manager Transparency Act (S. 526), to help lower out-of-pocket prescription drug costs for Americans.
Mark Blum, managing director of the PBM Accountability Project, issued the following statement:
“We appreciate Senator Grassley and Senator Cantwell’s unwavering leadership in addressing harmful PBM pricing practices. As we have previously said, these bills take critical steps toward curbing predatory PBM practices that drive up prescription drug costs for patients, employers and unions.
“Late last year, Congress had the opportunity to take meaningful action on PBM reform but failed to get it done. Now, early this year, it is more urgent than ever for Congress to make PBM reform a top priority and finally deliver the transparency and accountability that Americans deserve.
“These bills will expose hidden PBM profit schemes, eliminate harmful practices like spread pricing and reimbursement clawbacks, and provide much-needed oversight of the largest PBMs that control over 80% of drug purchasing. The time for action is now—Congress must act swiftly to rein in PBMs and restore fairness to the prescription drug marketplace.”
To learn more about the PBM issue and legislative solutions, click here.
コメント